How much are peptides? Research peptides run from about one dollar to several hundred dollars per milligram. Length, hard residues, purification and lot testing drive the price. A vial price means little across suppliers until you convert it to cost per milligram of actual peptide and read the certificate behind it.
- Vial price is not comparable across suppliers until it is corrected for stated peptide content, which is often between 70 and 90 percent of vial mass.
- Chromatographic purity and peptide content are separate assays answering different questions, and a lot can score high on one and low on the other.
- Per-milligram cost falls steeply across the first order of magnitude of batch scale because synthesis carries a large fixed cost per run.
- Area-percent purity by RP-HPLC depends entirely on the gradient, column and system suitability behind it, so a percentage without a named method is unqualified.
- A certificate of analysis for research-grade material establishes identity and purity only, and is not a release document for any use in humans or animals.
- For most small studies the cost of one failed run exceeds the entire compound budget, which is the practical argument for the better-documented lot.
How much are peptides, and why is there no single answer?
A short, unmodified five-residue peptide made at scale can land under a dollar per milligram. A forty-residue sequence carrying a lipid conjugate, a non-coded residue and a disulfide bridge, purified to 98 percent and supplied with mass-spectrometric identity confirmation, can cost two or three orders of magnitude more for the same mass. Both are peptides. Asking what peptides cost is like asking what glassware costs.
Price also moves with quantity in a way that is not linear. Solid-phase synthesis has a fixed cost per run that barely changes between a 100 mg batch and a 1 g batch, so the per-milligram figure falls steeply across the first order of magnitude of scale and then flattens. This is why a 5 mg vial from a catalog supplier often works out at several times the per-milligram cost of the same sequence bought as a gram of bulk material, and why the two figures should never be quoted against each other as evidence of anything.
A purchasing chemist makes the numbers comparable first, then asks what the price pays for and which documents arrive with the material. Until then the price means very little.
- Start with vial price divided by labeled mass
- Multiply labeled mass by stated peptide content
- Recalculate per milligram of actual peptide
- Check purity against the named chromatographic method
- Add shipping, coolant and any counterion conversion
How do you compare cost per milligram instead of per vial?
The unit printed on a webshop is a vial. The unit that matters is a milligram of the compound. Converting between them takes two steps, and most people stop after the first.
Step one is the obvious division:
$42 ÷ 10 mg = $4.20 per mg (nominal)
Step two is the correction almost nobody applies. A certificate of analysis reports two separate numbers that are routinely confused. Chromatographic purity is the fraction of the peptide-related material that is the target sequence. Peptide content, sometimes called net peptide or assay by nitrogen, is the fraction of the vial mass that is peptide at all, the balance being water, residual counterion and salts. A trifluoroacetate salt from a TFA-containing purification can account for a substantial share of the mass, and hygroscopic lyophilizates pick up water.
So a vial labeled 10 mg, certified 98.4 percent pure with a peptide content of 78 percent, contains:
10 mg × 0.78 = 7.8 mg peptide
$42 ÷ 7.8 mg = $5.38 per mg (corrected)
| Offer | Vial price | Nominal $/mg | Stated peptide content | Corrected $/mg |
|---|---|---|---|---|
| Supplier A, 5 mg | $28 | $5.60 | Not stated | Unknown |
| Supplier B, 10 mg | $42 | $4.20 | 78% | $5.38 |
| Supplier C, 10 mg | $51 | $5.10 | 91% | $5.60 |
| Supplier D, 100 mg bulk | $310 | $3.10 | 85% | $3.65 |
Read the table for what it does to the ranking. On vial price, A looks mid-range and B looks cheapest. On the corrected basis, B and C are within four percent of each other and A cannot be scored at all, because a certificate that omits peptide content leaves you buying an unknown quantity of your compound. The cost per mg tool does this arithmetic across offers.
How much do peptides cost to make, and what drives the price?
Two suppliers quoting the same sequence at very different prices are usually not selling the same thing. The gap is generally traceable to identifiable cost inputs rather than to margin alone.
| Driver | Effect on price | Why |
|---|---|---|
| Sequence length | Rises steeply past roughly 30 residues | Coupling yields compound; a 0.5% loss per cycle is invisible at 8 residues and severe at 40 |
| Difficult residues | Moderate to large | Arginine, cysteine and sterically hindered or non-coded residues need longer couplings and extra protecting-group strategy |
| Post-synthetic modification | Large | Lipidation, cyclization, disulfide formation and site-specific conjugation each add steps and each loses material |
| Target purity | Non-linear | Moving 95% to 99% can mean a second preparative chromatography pass and a substantial yield sacrifice |
| Counterion exchange | Moderate | Acetate salt instead of TFA requires an additional ion-exchange or lyophilization cycle |
| Analytical package | Small per unit, real per lot | RP-HPLC, LC-MS, water content, endotoxin or bioburden where specified, each with instrument time and an analyst |
| Batch scale | Falls with scale, then flattens | Fixed per-run cost dominates at milligram scale |
| Cold chain and packaging | Fixed, often unbundled | Insulated shipping and coolant are charged separately by many suppliers; see shipping conditions |
Anything priced conspicuously below the range for its class deserves a specific question rather than general suspicion: which of those inputs was omitted. Sometimes the honest answer is scale, and the material is fine. Sometimes the answer is that the lot was never independently tested.
What documents have to arrive with the material?
Price without documentation is not a price, because the quantity and identity of what you bought are unestablished. A certificate of analysis for a synthetic peptide lot should carry, at minimum, the following, and each item should be tied to the specific lot rather than to the product line.
- Lot or batch identifier, and it must match the vial label
- Sequence in one-letter or three-letter code, with modifications and termini stated explicitly
- Molecular formula and monoisotopic or average molecular weight
- Chromatographic purity with the method named: column chemistry, mobile phase, gradient, detection wavelength
- An actual chromatogram, not just a number
- Mass-spectrometric identity confirmation with the observed mass, and the deconvoluted or charge-state assignment where relevant
- Peptide content and the method used to determine it
- Water content, typically by Karl Fischer or loss on drying
- Counterion identity
- Appearance, and the date of analysis
Two omissions are worth treating as disqualifying. A purity figure without a chromatogram cannot be checked, and area-percent purity at one wavelength is a weaker claim than most buyers assume. A stated mass without a spectrum is a typed number. Both are cheap to supply if the analysis was run.
Certificates that carry a facility name, a signature and an analysis date within a plausible window of the manufacture date are ordinary practice. Certificates that are dated years before the lot, or that show identical retention times and peak areas across visibly different products, have been seen often enough that checking is worth the minute it takes. Our own documentation baseline is set out under the quality standard.
How do you read the purity number?
Reverse-phase HPLC with UV detection near 214 nm is the standard purity method for synthetic peptides, because the peptide backbone absorbs there. It reports area percent: the target peak as a fraction of total integrated peak area under the stated conditions. That last clause carries most of the weight.
A shallow gradient resolves closely related impurities such as deletion sequences, deamidated species and diastereomers. A steep gradient can bury them under the main peak and return a flattering number from the same sample. USP General Chapter <621> sets out the system suitability expectations that make a chromatographic result meaningful, including resolution, tailing and repeatability, and a certificate that reports none of them is reporting an unqualified figure. Two suppliers can both state 99 percent honestly and be describing materially different preparations.
Nor does UV area percent see everything. Counterion, water, residual solvents and inorganic salts do not absorb at 214 nm and do not appear in that denominator, which is exactly why peptide content is a separate assay. A lot can be 99.2 percent pure by HPLC and 74 percent peptide by mass. Both numbers are true and they answer different questions.
Where a downstream method is sensitive to residual TFA, ask which counterion the lot carries before ordering rather than after. Conversion after the fact is possible and is not free.
How do you vet a supplier without relying on the website?
Marketing copy converges. Documentation practice does not. A short diligence sequence separates them, and none of it requires a purchase.
- Request the certificate for a specific in-stock lot before ordering. A supplier who cannot produce one for material already on the shelf is telling you something.
- Check whether third-party testing is offered and who performs it. Independent laboratory reports on named lots, with the analysis date visible, carry more weight than an internal certificate.
- Compare the stated molecular weight against a public reference such as PubChem for the parent compound. Arithmetic mismatches happen and are diagnostic.
- Ask how the material is stored and shipped, and whether coolant is used in summer months. Dry lyophilized powder tolerates short ambient excursions; the answer still tells you how the operation thinks.
- Ask what happens if a lot fails your incoming inspection. A written return position exists or it does not.
- Check whether diluent is sold as a separate documented item, and on what basis.
Red flags, plainly: no lot-specific certificate; purity claims without a method; identical chromatograms across products; dosing or health language anywhere on the site, which indicates a customer base that is not doing laboratory work and a supplier who has accepted that; pricing far outside the range for the sequence class with no scale explanation; and any refusal to name the counterion or the peptide content.
None of this makes a cheap lot bad or an expensive lot good. It makes the comparison possible, which is all a purchasing decision needs.
How do you budget a study rather than a vial?
The per-milligram figure is an input, not the answer. The number that matters to a project is cost per experiment, and it usually moves for reasons unrelated to catalog price.
Take a protocol requiring 0.4 mg of material per run across 30 runs, with a 25 percent allowance for losses in handling, adsorption and repeat work:
0.4 mg × 30 = 12 mg
12 mg × 1.25 = 15 mg required
At a corrected $5.38 per mg that is roughly $81 of compound, and buying it as two 10 mg vials rather than three 5 mg vials will typically save more than shopping the vial price between suppliers. Against that sits the cost of a failed run: a single wasted week of instrument time and analyst hours will exceed the entire compound budget for most small studies. That asymmetry is the practical argument for buying the better-documented lot when the price gap is a few dollars per milligram, and it is an argument from bookkeeping rather than from quality as an abstraction.
Compound wasted through handling is indistinguishable, on the invoice, from compound wasted through overpaying.
What is the regulatory position of research peptides?
Synthetic peptides supplied for laboratory use are chemicals, not approved drug products. They are not manufactured under pharmaceutical quality systems covering sterility, endotoxin limits, formulation or lot release for human use, and no regulatory agency has reviewed them for safety or efficacy. Some sequences sold as research chemicals are also the active ingredient of approved prescription medicines; the existence of an approved medicine says nothing about the research-grade powder, which comes from a different supply chain with a narrower set of claims attached.
A certificate of analysis for a research lot establishes identity and purity under a stated method. It is not a release document for human or veterinary use and does not become one at any purity level.
Status verified August 26, 2026.
FOR LABORATORY AND IN-VITRO RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR PERSONAL, MEDICAL, DIAGNOSTIC, THERAPEUTIC, OR RECREATIONAL USE.
Bottom line
Compare peptide prices per milligram of actual peptide, corrected for the stated peptide content, and only within a sequence class. A price with no lot-specific certificate behind it is not much of a price, because the quantity and identity of what you bought are unestablished. When two documented lots differ by a few dollars per milligram, the cost of one failed run usually settles it in favor of the better-documented lot.
Common questions
How much are peptides for research?
Why is peptide content lower than purity on a certificate?
Is a 99 percent purity claim better than 98 percent?
Does buying in bulk always reduce cost per milligram?
What single document should I insist on before ordering?
More procurement guides
Sources
- United States Pharmacopeia, General Chapter <621> Chromatography. Defines system suitability requirements including resolution, tailing factor and repeatability; supports the point that an area-percent purity figure is only interpretable alongside its stated method conditions.
- ICH Q2(R2), Validation of Analytical Procedures. Establishes the validation characteristics expected of identity, purity and assay methods; supports the distinction between a reported number and a qualified measurement on a certificate of analysis.
- PubChem, NIH National Library of Medicine. Public reference for molecular formula and molecular weight of named compounds; supports the diligence step of checking certificate mass values against an independent source.
- D'Hondt and colleagues. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis 101:2-30 . Basis for the yield and purification discussion: this review catalogs the deletion, truncation and modification impurities that solid-phase synthesis produces and that purification has to remove, which is where the cost sits.
